First Pet Life, Inc. engages in the provision of pet health insurance, pet supplies, boarding, and grooming services. The company is headquartered in Dallas, Texas. The company went IPO on 2004-04-08.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue
31
28
33
43
30
15
Revenue Growth (YoY)
35%
-15%
-23%
43%
100%
275%
Cost of Revenue
13
12
13
15
12
9
Gross Profit
17
15
20
27
17
5
Selling, General & Admin
45
41
41
37
38
27
Research & Development
--
8
9
15
14
11
Operating Expenses
60
50
45
53
52
38
Other Non Operating Income (Expenses)
0
0
0
0
0
0
Pretax Income
-43
-38
-26
-37
-35
-47
Income Tax Expense
--
0
0
1
0
--
Net Income
-46
-39
-26
-41
-36
-48
Net Income Growth
70%
50%
-37%
14%
-25%
4%
Shares Outstanding (Diluted)
16
15.34
13.36
13.64
13.61
11.04
Shares Change (YoY)
18%
15%
-2%
0%
23%
15%
EPS (Diluted)
-2.9
-2.56
-2.02
-3.01
-2.69
-4.37
EPS Growth
43%
27%
-33%
12%
-38%
-9%
Free Cash Flow
--
-29
-22
-26
-42
-45
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
54.83%
53.57%
60.6%
62.79%
56.66%
33.33%
Operating Margin
-135.48%
-121.42%
-75.75%
-60.46%
-116.66%
-220%
Profit Margin
-148.38%
-139.28%
-78.78%
-95.34%
-120%
-320%
Free Cash Flow Margin
--
-103.57%
-66.66%
-60.46%
-140%
-300%
EBITDA
--
-32
-22
-24
-34
-32
EBITDA Margin
--
-114.28%
-66.66%
-55.81%
-113.33%
-213.33%
D&A For EBITDA
--
2
3
2
1
1
EBIT
-42
-34
-25
-26
-35
-33
EBIT Margin
-135.48%
-121.42%
-75.75%
-60.46%
-116.66%
-220%
Effective Tax Rate
--
0%
0%
-2.7%
0%
--
Follow-Up Questions
What are First Pet Life Inc's key financial statements?
According to the latest financial statement (Form-10K), CASI Pharmaceuticals Inc has a total asset of $53, Net loss of $-39
What are the key financial ratios for FPLF?
CASI Pharmaceuticals Inc's Current ratio is 1.03, has a Net margin is -139.28, sales per share of $1.82.
How is First Pet Life Inc's revenue broken down by segment or geography?
CASI Pharmaceuticals Inc largest revenue segment is Pharmaceutical Products, at a revenue of 28,537,000 in the most earnings release.For geography, China is the primary market for CASI Pharmaceuticals Inc, at a revenue of 28,537,000.
Is First Pet Life Inc profitable?
no, according to the latest financial statements, CASI Pharmaceuticals Inc has a net loss of $-39
Does First Pet Life Inc have any liabilities?
yes, CASI Pharmaceuticals Inc has liability of 51
How many outstanding shares for First Pet Life Inc?
CASI Pharmaceuticals Inc has a total outstanding shares of 15.49